Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1981 1
1987 1
1988 1
1989 1
1990 5
1991 3
1992 4
1995 1
1998 1
1999 1
2000 1
2002 1
2003 5
2004 4
2005 5
2006 6
2007 1
2008 1
2009 2
2010 1
2011 2
2012 1
2015 2
2016 1
2017 3
2019 1
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Insulin-receptor tyrosine kinase and glucose transport.
Lane MD, Flores-Riveros JR, Hresko RC, Kaestner KH, Liao K, Janicot M, Hoffman RD, McLenithan JC, Kastelic T, Christy RJ. Lane MD, et al. Among authors: janicot m. Diabetes Care. 1990 Jun;13(6):565-75. doi: 10.2337/diacare.13.6.565. Diabetes Care. 1990. PMID: 2162754 Review.
TGF-β2 silencing to target biliary-derived liver diseases.
Dropmann A, Dooley S, Dewidar B, Hammad S, Dediulia T, Werle J, Hartwig V, Ghafoory S, Woelfl S, Korhonen H, Janicot M, Wosikowski K, Itzel T, Teufel A, Schuppan D, Stojanovic A, Cerwenka A, Nittka S, Piiper A, Gaiser T, Beraza N, Milkiewicz M, Milkiewicz P, Brain JG, Jones DEJ, Weiss TS, Zanger UM, Ebert M, Meindl-Beinker NM. Dropmann A, et al. Among authors: janicot m. Gut. 2020 Sep;69(9):1677-1690. doi: 10.1136/gutjnl-2019-319091. Epub 2020 Jan 28. Gut. 2020. PMID: 31992593 Free PMC article.
Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma.
Seystahl K, Papachristodoulou A, Burghardt I, Schneider H, Hasenbach K, Janicot M, Roth P, Weller M. Seystahl K, et al. Among authors: janicot m. Mol Cancer Ther. 2017 Jun;16(6):1177-1186. doi: 10.1158/1535-7163.MCT-16-0465. Epub 2017 Apr 4. Mol Cancer Ther. 2017. PMID: 28377490 Free article.
Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic.
van den Bosch MTJ, Yahyanejad S, Alemdehy MF, Telford BJ, de Gunst T, den Boer HC, Vos RM, Stegink M, van Pinxteren LAH, Schaapveld RQJ, Janicot M. van den Bosch MTJ, et al. Among authors: janicot m. Mol Ther Nucleic Acids. 2021 Jan 26;23:1161-1171. doi: 10.1016/j.omtn.2021.01.020. eCollection 2021 Mar 5. Mol Ther Nucleic Acids. 2021. PMID: 33664995 Free PMC article.
Design and analysis of drug combination experiments.
Straetemans R, O'Brien T, Wouters L, Van Dun J, Janicot M, Bijnens L, Burzykowski T, Aerts M. Straetemans R, et al. Among authors: janicot m. Biom J. 2005 Jun;47(3):299-308. doi: 10.1002/bimj.200410124. Biom J. 2005. PMID: 16053254 Free article.
Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology.
Telford BJ, Yahyanejad S, de Gunst T, den Boer HC, Vos RM, Stegink M, van den Bosch MTJ, Alemdehy MF, van Pinxteren LAH, Schaapveld RQJ, Janicot M. Telford BJ, et al. Among authors: janicot m. Oncotarget. 2021 Mar 2;12(5):422-439. doi: 10.18632/oncotarget.27894. eCollection 2021 Mar 2. Oncotarget. 2021. PMID: 33747358 Free PMC article.
61 results